NOVADAQ RECEIVES FDA CLEARANCE FOR SPY LABELING CHANGES

Novadaq Technologies Inc., a developer of medical imaging systems for the operating room, announced May 9 that it has received a 510(k) pre-market clearance from the United States Food and Drug Administration for a labeling revision for its SPY Intra-operative Imaging System. This labeling will give cardiac surgeons greater flexibility for the administration of the imaging agent while enhancing image quality during coronary artery bypass graft (CABG) procedures.
CNW Telbec